Retracted: Actin‑like protein 8 executes a promoting function in the malignant progression of endometrial cancer: identification of a promising biomarker
Author:
Affiliation:
1. Department of Obstetrics and Gynecology, The Second Hospital of Shandong University, Shandong, P.R. China
2. Department of Central Laboratory, The Second Hospital of Shandong University, Shandong, P.R. China
Publisher
Oxford University Press (OUP)
Subject
Organic Chemistry,Molecular Biology,Applied Microbiology and Biotechnology,General Medicine,Biochemistry,Analytical Chemistry,Biotechnology
Link
https://academic.oup.com/bbb/article-pdf/84/6/1160/42243682/bbb1160.pdf
Reference38 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. Endometrial cancer: not your grandmother’s cancer.%A McAlpine JN;Sm;Cancer,2016
3. Medical therapy of endometrial cancer: current status and promising novel treatments;Hill;Drugs,2012
4. Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC clinical trials group;Oza;J Clin Oncol,2011
5. Stage I endometrial adenocarcinoma: treatment results in 835 patients;Lotocki;Am J Obstet Gynecol,1983
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Transcriptome analysis of human preimplantation embryo reveals expressed waves associated with blastulation failure based on embryonic grade and age;2022-06-04
2. Actin-like protein 8, a member of cancer/testis antigens, supports the aggressive development of oral squamous cell carcinoma cells via activating cell cycle signaling;Tissue and Cell;2022-04
3. Retraction to: Actin-like protein 8 executes a promoting function in the malignant progression of endometrial cancer: identification of a promising biomarker;Bioscience, Biotechnology, and Biochemistry;2022-01-25
4. ACTL6A promotes the growth in non-small cell lung cancer by regulating Hippo/Yap pathway;Experimental Lung Research;2021-04-24
5. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway;OncoTargets and Therapy;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3